Interleukin-6 production by activated human monocytic cells is enhanced by MK-571, a specific inhibitor of the multi-drug resistance protein-1

Por Vellenga, Edo, Tuyt, Leonore, Wierenga, Bart-Jan, Müller, Michael, Dokter, Wim
Publicado em 1999

Assessing the metabolic effects of prednisolone in healthy volunteers using urine metabolic profiling

Por Ellero-Simatos, Sandrine, Szymańska, Ewa, Rullmann, Ton, Dokter, Wim HA, Ramaker, Raymond, Berger, Ruud, van Iersel, Thijs MP, Smilde, Age K, Hankemeier, Thomas, Alkema, Wynand
Publicado em 2012

Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor

Por Frijters, Raoul, Fleuren, Wilco, Toonen, Erik JM, Tuckermann, Jan P, Reichardt, Holger M, van der Maaden, Hans, van Elsas, Andrea, van Lierop, Marie-Jose, Dokter, Wim, de Vlieg, Jacob, Alkema, Wynand
Publicado em 2010

Prednisolone induces the Wnt signalling pathway in 3T3-L1 adipocytes

Por Fleuren, Wilco W. M., Linssen, Margot M. L., Toonen, Erik J. M., van der Zon, Gerard C. M., Guigas, Bruno, de Vlieg, Jacob, Dokter, Wim H. A., Ouwens, D. Margriet, Alkema, Wynand
Publicado em 2013

Activation of Proteinase 3 Contributes to Nonalcoholic Fatty Liver Disease and Insulin Resistance

Por Toonen, Erik JM, Mirea, Andreea-Manuela, Tack, Cees J, Stienstra, Rinke, Ballak, Dov B, van Diepen, Janna A, Hijmans, Anneke, Chavakis, Triantafyllos, Dokter, Wim H, Pham, Christine TN, Netea, Mihai G, Dinarello, Charles A, Joosten, Leo AB
Publicado no Mol Med (2016)

A comparison of anti-HER2 IgA and IgG1 in vivo efficacy is facilitated by high N-glycan sialylation of the IgA

Por Rouwendal, Gerard JA, van der Lee, Miranda M, Meyer, Saskia, Reiding, Karli R, Schouten, Jan, de Roo, Guy, Egging, David F, Leusen, Jeanette HW, Boross, Peter, Wuhrer, Manfred, Verheijden, Gijs F, Dokter, Wim H, Timmers, Marco, Ubink, Ruud
Publicado no MAbs (2015)

Glucose Kinetics in the Collagen-Induced Arthritis Model: An All-in-One Model to Assess Both Efficacy and Metabolic Side Effects of Glucocorticoids

Por Toonen, Erik J. M., Laskewitz, Anke J., van Dijk, Theo H., Bleeker, Aycha, Grefhorst, Aldo, Schouten, Annelies E., Bastiaanssen, Ellen A. J., Ballak, Dov B., Koenders, Marije I., van Doorn, Cindy, van der Vleuten, Monique A. J., van Lierop, Marie-Jose C., Groen, Albert K., Dokter, Wim H. A.
Publicado em 2014

Org 214007-0: A Novel Non-Steroidal Selective Glucocorticoid Receptor Modulator with Full Anti-Inflammatory Properties and Improved Therapeutic Index

Por van Lierop, Marie-José C., Alkema, Wynand, Laskewitz, Anke J., Dijkema, Rein, van der Maaden, Hans M., Smit, Martin J., Plate, Ralf, Conti, Paolo G. M., Jans, Christan G. J. M., Timmers, C. Marco, van Boeckel, Constant A. A., Lusher, Scott J., McGuire, Ross, van Schaik, Rene C., de Vlieg, Jacob, Smeets, Ruben L., Hofstra, Claudia L., Boots, Annemieke M. H., van Duin, Marcel, Ingelse, Benno A., Schoonen, Willem G. E. J., Grefhorst, Aldo, van Dijk, Theo H., Kuipers, Folkert, Dokter, Wim H. A.
Publicado em 2012